The importance of dose and schedule in chemotherapy for small cell lung cancer.
AffiliationCRC Department of Medical Oncology, University of Manchester, UK.
MetadataShow full item record
AbstractTo improve the survival outlook for patients with small cell lung cancer a variety of chemotherapy strategies has been adopted. This review focuses on the evidence for schedule dependency, particularly with regard to etoposide, and reviews the use of alternating chemotherapy protocols and weekly regimens in small cell lung cancer treatment. Recent improvements in supportive care, with the use of haemopoietic growth factors and peripheral blood progenitor cells, have led to renewed interest in the concept of dose intensity. Preliminary results of dose intensification in small cell lung cancer are described and future prospects discussed.
CitationThe importance of dose and schedule in chemotherapy for small cell lung cancer. 1995, 6 Suppl 5:53-63 Anticancer Drugs
- Chemotherapy dose intensity in small cell lung cancer.
- Authors: Souhami RL, De Elvira MC
- Issue date: 1994 Mar
- Developments in therapy for extensive-disease small cell lung cancer.
- Authors: Comis RL
- Issue date: 1992 Dec
- Increasing chemotherapy in small-cell lung cancer: from dose intensity and density to megadoses.
- Authors: Crivellari G, Monfardini S, Stragliotto S, Marino D, Aversa SM
- Issue date: 2007 Jan
- [Chemotherapy of small cell lung cancer].
- Authors: Komiya T, Takada M
- Issue date: 1996 Aug
- Chemotherapy dose intensity facilitated by use of lenograstim--implications for quality of life and survival.
- Authors: Gisselbrecht C
- Issue date: 1994